Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jill Leversage Insider Profile
4 Followers
Jill Leversage, Director at Aurinia Pharmaceuticals, holds 12.92K shares in Aurinia Pharmaceuticals (Ticker: AUPH). Most recently, Jill Leversage Sold $5,610 shares of Aurinia Pharmaceuticals on May 22, 2024 for an estimated value of 32.20K.
Jill Leversage Aurinia Pharmaceuticals (AUPH)Director
Aurinia Pharmaceuticals (AUPH)
Director
Ranked #78,686 out of 98,042 Corporate Insiders
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-30.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Jill Leversage holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jill Leversage
Jill Leversage's Trading History
List of latest transactions for each holding click on a transaction to see Jill Leversage's performance on stock
You May Also Like
Jill Leversage insider profile FAQ
What is the percentage of profitable transactions made by Jill Leversage?
The percentage of profitable transactions made by Jill Leversage is 0%.
What is the average return per transaction made by Jill Leversage?
The average return per transaction made by Jill Leversage is -30.00%.
What stocks does Jill Leversage hold?
Jill Leversage holds: AUPH stocks.
What was Jill Leversage’s latest transaction?
Jill Leversage latest transaction was an Informative Sell of $32.20K.
What was Jill Leversage's most profitable transaction?
Jill Leversage’s most profitable transaction was an Informative Sell of AUPH stock on May 22, 2024. The return on the trade was -0.50%.
What is Jill Leversage's role in Aurinia Pharmaceuticals?
Jill Leversage's role in Aurinia Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.